China: Great Wall or new El Dorado for Life Sciences Industry?

Paris Health Care Drinks Reception

China has been undertaking drastic reforms to accelerate innovation in order to match the country’s increasing demand in health care. For foreign companies, this means new opportunities but also potentially new challenges access this tremendous market.

Join us for an evening of discussion on new rules relating to regulatory reform, IP protection and changing fiscal legislation that will greatly alter the landscape for foreign biotech & medtech companies seeking to expand to China.

Our guest speakers will also share with you their experience as regards to collaboration and developing business in this changing environment.

After an opportunity to engage with the speakers, we invite you to a networking drinks reception.